Etopa Injection contains Etoposide 100mg, a chemotherapeutic agent used primarily in the treatment of various malignancies including lung cancer, testicular cancer, lymphoma, and certain types of leukemia. Etoposide works by inhibiting the enzyme topoisomerase II, which is essential for DNA replication and cell division, thereby preventing cancer cell proliferation and inducing apoptosis. This injection is administered intravenously under strict medical supervision, typically in a hospital or clinical setting, to ensure accurate dosing and monitor for adverse effects. Common side effects may include nausea, vomiting, hair loss, low blood cell counts leading to increased risk of infection, anemia, and bleeding tendencies. Patients receiving Etopa Injection require regular blood tests to monitor blood cell levels and liver function. It is contraindicated in individuals with hypersensitivity to etoposide or its components and should be used cautiously in patients with impaired liver or kidney function. Pregnant or breastfeeding women should avoid this medication due to potential harm to the fetus or infant. Etopa Injection is a vital component of combination chemotherapy regimens and should only be used under the guidance of an oncologist experienced in cancer treatment protocols.